Overview

To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of pregabalin in patients with painful diabetic peripheral neuropathy.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin